1. Stern Investor Relations is a leading investor relations (IR) firm specializing in providing IR consulting services to
biotechnology and healthcare companies in the U.S. and around the world. Since our inception in 1998, we have
worked with over 200 companies in all stages of development and in a wide range of clinical indications, including
bellwethers in the industry, small- and mid-cap companies, recent IPOs and private companies.
Specialization in Healthcare IR
clients • We possess an extensive, detailed and up-to-the-minute knowledge of the
ACCeleROn PHARmA, InC. sector, regulatory issues and the current market environment.
ACORdA THeRAPeUTICS InC. • We closely monitor industry trends to provide a comprehensive approach
AlkeRmeS, InC. to investor relations counsel.
AlnylAm PHARmACeUTICAlS, InC.
Relationships with the Investment Community
AmAG PHARmACeUTICAlS, InC.
• We have cultivated many valuable relationships within the investment
ARCHemIx CORP.
community and know the major players and industry events.
BIOSPeCIFICS TeCHnOlOGIeS CORP.
• We facilitate introductions with crucial contacts on Wall Street and help
CURIS, InC.
our clients develop and improve existing relationships.
ImmUnOGen, InC.
Focus on Best Industry Practice
InTeRleUkIn GeneTICS, InC.
• We believe that high-quality companies should operate their IR programs
IROnWOOd PHARmACeUTICAlS, InC.
according to current best industry practice.
lUx BIOSCIenCeS, InC.
• We advise our clients accordingly, helping them convey news and
mIllennIUm: THe TAkedA OnCOlOGy COmPAny
information to research analysts and investors regularly and consistently,
mOmenTA PHARmACeUTICAlS, InC.
with special attention to timing, positioning, accuracy and fair disclosure
TOkAI PHARmACeUTICAlS, InC.
policies.
VeRenIUm CORPORATIOn
ApproAch
Our ultimate goal is to help each client realize a valuation that best reflects
the company’s assets and the internal value of the company through favor-
able interactions with the investment community.
We believe that a successful investor relations program depends on a
multifaceted approach, including effective strategy and also tactical execu-
tion. Thoughtful strategic advice, commitment to execution and a careful
attention to detail are central to our approach.
We aim to provide cost-effective investor relations counsel and support and
to maximize the impact of our clients’ time and effort.
Stern Investor Relations, Inc. ■ new york, ny ■ 212.362.1200 ■ Info@sternir.com ■ Copyright 2009
2. serVices teAM
Our team of experienced, analytical, IR professionals offers a
Working closely with each client, we develop and execute custom-
proven track record of delivering results. years of experience and
ized strategic investor relations programs designed to manage com-
superior client service allow us to provide sophisticated and critical
munications effectively with the investment community. Committed
direction, unique insights and a total perspective to meet clients’
to superior client service, we provide each client with senior level
needs.
attention, strategic counsel and critical, disciplined tactical support.
lilian Stern, Principal and Founder, has been a senior IR
Stern IR offers a broad range of investor relations services that often
counselor in the biotechnology industry for over 15 years,
includes working with senior management to achieve key investor
representing more than 200 companies. Prior to founding Stern
relations goals, such as effective positioning, enhancing visibility,
IR, lilian established and ran the investor relations group at Burns
improving institutional ownership and sell-side coverage, preparing
mcClellan for six years and worked as a biotechnology sell-side
for financings and IPOs, developing good guidance practices and
analyst at donaldson, lufkin & Jenrette/Credit Suisse First Bos-
managing communications around m&A, binary events and other
ton. She holds an A.B. with distinction from Cornell University and
strategic issues.
a J.d. with honors from Harvard law School.
Strategic IR
• We emphasize the importance of strategic planning. each
relationship begins with an analysis of the client’s investment
considerations, including perceived strengths and challenges and
upcoming news items and milestones.
• We then develop documents to help guide our communications
and outreach strategies, including corporate messaging, a client-
catered yearly calendar, an outreach plan and a sophisticated
analyst and investor targeting analysis program.
Tactical IR
• We provide full tactical and event planning support, assisting with
various IR events, including roadshows (sell-side, bank-sponsored,
non-deal and investor conferences), Analyst and Investor days and
events, earnings and news announcements and events at medical
meetings.
• We assist with the development of news releases, fact sheets,
FAQs, annual reports and other IR-related documents.
Stern Investor Relations, Inc. ■ new york, ny ■ 212.362.1200 ■ Info@sternir.com ■ Copyright 2009